Clinical Trial Update: Exposure, D-Cycloserine Enhancement, and Genetic Modulators in Panic Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial in panic disorder evaluated exposure-based therapy with D-Cycloserine enhancement and genetic modulators; results have been posted after …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Panic Disorder

Drugs mentioned

• D-cycloserine (D-cycloserine)

Snippet

Sponsor: Boston University Charles River Campus | Conditions: Panic Disorder | Phase 2 | Status: COMPLETED | Results posted: 2018-03-07